Raffray M, Cohen G M
Department of Pharmacology, The School of Pharmacy, University of London, UK.
Arch Toxicol. 1991;65(2):135-9. doi: 10.1007/BF02034940.
In order to characterise the mechanism of cytotoxicity of the immunotoxic organotin compound bis(tri-n-butyltin)oxide (TBTO) to lymphoid cells, isolated thymocytes from immature rats were exposed to TBTO (0.1-5 microM) for up to 6 h. At lower TBTO concentrations (0.1 and 1 microM) vital staining showed that only marginal loss of viability occurred, although morphological studies demonstrated increased numbers of cells with abnormal features indicative of programmed cell death (apoptosis). These changes included nuclear chromatin condensation (which was associated with increased DNA fragmentation), cytoplasmic contraction and formation of membrane bound apoptotic bodies. When visualised by agarose gel electrophoresis, genomic DNA appeared as a series of fragments with a repeat multiple of 180-200 base pairs. Comparable morphological changes and cleavage of DNA into oligonucleosomal fragments were evident in thymocytes incubated with 10 microM methyl prednisolone hemisuccinate (MPS); a glucocorticoid hormone known to induce programmed cell death in thymocytes. Marked cytotoxicity associated with degenerative changes indicative of necrosis was observed in thymocytes incubated with 5 microM TBTO. These findings indicate that, at levels which are not overtly cytotoxic, TBTO is capable of inducing programmed cell death in rat thymocytes. This suggests a possible mechanism for the T-cell immunodeficiency previously reported for TBTO in vivo.
为了阐明免疫毒性有机锡化合物双(三正丁基锡)氧化物(TBTO)对淋巴细胞的细胞毒性机制,将未成熟大鼠分离的胸腺细胞暴露于TBTO(0.1 - 5微摩尔)长达6小时。在较低的TBTO浓度(0.1和1微摩尔)下,活细胞染色显示仅发生了轻微的活力丧失,尽管形态学研究表明具有指示程序性细胞死亡(凋亡)的异常特征的细胞数量增加。这些变化包括核染色质浓缩(这与DNA片段化增加有关)、细胞质收缩和膜结合凋亡小体的形成。当通过琼脂糖凝胶电泳观察时,基因组DNA呈现为一系列重复倍数为180 - 200个碱基对的片段。在用10微摩尔半琥珀酸甲泼尼龙(MPS)孵育的胸腺细胞中也明显出现了类似的形态学变化和DNA切割成寡核小体片段的现象;MPS是一种已知可诱导胸腺细胞程序性细胞死亡的糖皮质激素。在用5微摩尔TBTO孵育的胸腺细胞中观察到与指示坏死的退行性变化相关的明显细胞毒性。这些发现表明,在未表现出明显细胞毒性的水平下,TBTO能够诱导大鼠胸腺细胞程序性细胞死亡。这提示了先前在体内报道的TBTO所致T细胞免疫缺陷的一种可能机制。